Cerevel Therapeutics Holdings, Inc. (CERE)
Market Closed
31 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
44. 96
+0.33
+0.7394%
$
8.19B Market Cap
- P/E Ratio
- Div Yield
15.03M Volume
- Eps
$ 44.63
Previous Close Want to track CERE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
CERE Earnings Reports FAQ
What is the earnings per share (EPS) for CERE?
EPS data for CERE is currently not available, as Cerevel Therapeutics Holdings, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Cerevel Therapeutics Holdings, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Cerevel Therapeutics Holdings, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Cerevel Therapeutics Holdings, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CERE at this time, as Cerevel Therapeutics Holdings, Inc has no recent EPS data to calculate it.
